Podcasts by The Health Kick Podcast with Tim Boreham
Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications.
In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery.
Further podcasts by Stockhead
Podcast on the topic Gesundheit und Fitness
All episodes
PTX partners with the US's largest cancer centre to continue development of personalised cancer treatment from 2022-09-09T09:45
In this episode Tim chats to Steven Yatomi-Clarke, CEO of Prescient Therapeutics (ASX:PTX).
Listen
NGS's growth just accelerated with launch into 403 select Walmart stores from 2022-08-25T12:07
In this episode Tim sits down with Liron Fendell, CEO and Managing Director of Nutritional Growth Solutions (ASX:NGS)
Listen
Bionomic charges forward with lead drug candidate treatment for ptsd and social anxiety disorder from 2022-08-17T16:11
In this episode Tim sits down with Dr Errol De Souza, Executive Chairman at Bionomics (ASX:BNO)
Listen
How Osteopore is innovating in the area of bone and tissue regeneration from 2022-08-10T13:48
In this episode Tim chats to Mark Leong, non executive chairman at Osteopore (ASX:OSX)
Listen
Audeara's revenue up nearly 140% YoY - up 50% from the previous quarter from 2022-02-17T16:57
In this episode Tim chats to James Fielding co-founder and CEO of Audeara (ASX:AUA)
Listen
Life sciences expert David Williams on local medical innovations, tech leaders and sector opportunities from 2021-12-07T18:19
Tim chats with David Williams, Managing Director of Kidder Williams
Listen
ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies from 2021-11-30T10:53
Tim chats with Nina Webster, CEO & Managing Director of Dimerix Ltd (ASX:DXB).
Listen
TALi Digital is using gamification to spot hard-to-identify cognitive function and attention deficit issues in children from 2021-09-03T11:55
Tim chats Glenn Smith, Managing Director of Tali Digital (ASX:TD1)
Listen
Wellnex CEO George Karafotias discusses the company's wellness pivot, legacy product range and growth plans from 2021-08-26T10:51
Tim chat's with George Karafotias, Group CEO of Wellnex Life Ltd (ASX:WNX)
Listen
New ASX stock HitIQ has a revolutionary solution for the concussion problem in contact sport from 2021-08-20T09:35
In this episode Tim chats to Mike Vegar, Co-Founder & Managing Director at HitIQ (ASX:HIQ)
Listen
Prescient Therapeutics'YTD share price soars +220% following CAR-T and clinical study progress from 2021-08-19T12:40
In this episode Tim chats to Steven Yatomi-Clarke, CEO and Managing Director at Prescient Therapeutics (ASX:PTX)
Listen
New ASX listee Audeara uses algorithms to create perfect audio and better hearing health outcomes from 2021-06-07T12:45
In this edition Tim talks to James Fielding, CEO at Audeara (ASX:AUA).
Listen
Widely used injectable contrast dyes have serious health impacts, Osprey Medical has a solution from 2021-05-24T13:23
In this episode Tim chats to Mike McCormick, President & CEO of Osprey Medical (ASX:OSP)
Listen
New ASX player Control Bionics is commercialising tech that enables communication through neural signals from 2021-05-11T10:10
In this episode Tim chats to Rob Wong, CEO of Control Bionics (ASX:CBL)
Listen
Kazia tackles the curse of US politicians with its innovative drug candidate from 2021-03-12T11:27
In this episode Tim chats with James Garner, CEO at Kazia Therapeutics (ASX:KZA).
Listen
Entrepreneur Dr Chris Behrenbruch on taking Telix Pharma to a billion dollars, the future of nuclear medicine and more from 2021-03-08T13:06
This week Tim chats to Chris Behrenbruch, Bioscience Entrepreneur and CEO of Telix Pharmaceuticals Limited (ASX:TLX).
Listen
Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture from 2021-03-01T12:39
Tim chats with renowned Australian biotech entrepreneur Paul Hopper.
NSB brings new solutions to a handful medicine's most stubborn eye problems from 2021-02-04T12:38
This week Tim chats with Brian Leedman, chairman of NeuroScientific Biopharmaceuticals (ASX:NSB)
Listen
Neuren is cashed up, confident and charging into a phase 3 trial from 2020-11-26T12:02
This week Tim chats with Jon Pilcher, Chief Executive Officer at Neuren Pharmaceuticals (ASX:NEU)
Listen
The ASX's top performing 2019 IPO, Osteopore, discusses next steps, expansion plans and new markets from 2020-11-10T16:25
Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock.
Listen
Investors eye AdAlta's fibrosis fighting i-body platform from 2020-11-10T12:48
Tim chats with Tim Oldham, CEO and Managing Director of AdAlta Limited (ASX:1AD).
Listen
Investors smell success in Rhinomed's flu and coronavirus nasal swab technology from 2020-10-20T17:03
In this episode Tim chats with Michael Johnson, CEO & Executive Director of Rhinomed (ASX:RNO).
Listen
This biopharma company may be the world's only exosome-based player from 2020-10-14T13:46
In this episode Tim chats with Dr Chris Baldwin, Chief Commercial Officer of Exopharm (ASX:EX1)
Listen
Investor confidence is sky-high in Apiam's diversified pet and livestock veterinarian offering from 2020-09-18T15:05
Tim chats with Dr Chris Richards, Managing Director at Apiam Animal Health (ASX:AHX)
Listen
PainChek's AI-backed pain assessment technology is a game-changer for treating infants and the elderly from 2020-09-18T13:40
This week Tim chats with Philip Daffas, CEO & Managing Director at PainChek (ASX:PCK)
Listen
Investors still high on Incannex's cannabinoid pivot and COVID-19 treatment news from 2020-09-15T17:08
This week Tim chats with Dr Sud Agarwal, Chief Medical Officer at Incannex Healthcare (ASX: IHL)
Listen
Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray from 2020-08-31T16:22
This week Tim chats with Dr Jackie Fairley, CEO of Starpharma Holdings (ASX:SPL)
Listen
Cannpal has first mover advantage in the $67bn"hidden gem"animal health market from 2020-08-21T16:02
This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1).
Listen
Chemo's diminishing role, the'personalised'approach to cancer treatment and PTX's CAR-T innovations from 2020-08-18T17:40
This week Tim chats with Steven Yatomi-Clarke, CEO and Managing Director of Prescient Therapeutics (ASX:PTX)
Listen
Zelira's cannabis-derived insomnia treatment has investors dreaming from 2020-08-13T12:07
Tim chats with Dr Richard Hopkins, Managing Director of Zelira Therapeutics (ASX:ZLD)
Listen
Botanix is using synthetic cannabinoids to treat acne and other skin conditions from 2020-07-29T10:39
Tim chats with Matt Callahan, Executive Director of Botanix Pharmaceuticals (ASX: BOT)
Listen
Pancreatic cancer treater OncoSil continues impressive bounce-back from 2020-07-14T14:17
In this episode Tim chats with Daniel Kenny, Chief Executive Officer at OncoSil Medical (ASX: OSL).
Listen
This drug developer is up 200 percent after being included in a COVID-19 related trial from 2020-06-15T14:45
Dr Nina Webster, Managing Director and CEO of Dimerix (ASX:DXB)
Listen
VTI has a clear vision for the future of contact lenses from 2020-06-09T17:07
In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneering Technologies (ASX: VTI)
Listen
Cynata's stem cell therapy could be a game changer for COVID-19 patients from 2020-06-03T15:05
Tim chat's with Dr Ross Macdonald, CEO of Cynata Therapeutics (ASX:CYP).
Listen
Accurately measuring cognition offers massive upside to clinicians and drug makers, CGS is leading the charge from 2020-05-18T16:06
In this episode Tim chats with Brad O'Connor, Managing Director and CEO of CogState (ASX: CGS)
Listen
Can Aussie drug makers survive COVID-19? And what can we learn from Chemgenex success? from 2020-05-06T14:49
In this episode Tim chats with James Campbell, CEO of Patrys (ASX: PAB)
Listen
Chronic kidney disease is a worldwide health crisis, ASX-listed DXB driving improved treatment from 2020-04-15T10:07
In this episode Tim chats with Nina Webster, CEO and managing director of Dimerix (ASX: DXB)
Listen
Increasing athletic performance and fighting sleep apnea with a simple nose clip from 2020-03-31T11:28
In this episode Tim chats with Michael Johnson, Managing Director and CEO of Rhinomed (ASX:RNO).
Listen
Understanding immunotherapy, why the market dried up and Immutep's profitable potential from 2020-03-18T09:34
In this episode Tim chats with Marc Voigt, Executive Director and CEO of Immutep (ASX:IMM).
Listen
Memphasys is using electrical forces on sperm to get better IVF results from 2020-03-10T15:19
In this episode Tim chats with Alison Coutts, Executive Chairman of Memphasys (ASX:MEM).
Listen
Understanding the strategy and upside behind global cannabis investment company MMJ from 2020-03-05T16:12
In this episode Tim chats with Michael Curtis, director at MMJ Group Holdings (ASX:MMJ) and CEO of Embark Health.
Listen
Could oral sprays replace pills as a better means of drug delivery for some medicines? from 2020-03-03T16:52
In this episode Tim chats with Dr Michael Baker, CEO of Suda Pharmaceuticals (ASX:SUD).
Listen
The ASX's only medicinal honey player, the market post bush fires and what Amazon offers producers from 2020-02-26T15:52
In this episode Tim chats with Bill Fry, Managing Director of Eve Investments (ASX:EVE).
Listen
Skyrocketing prescription drug prices, Trump's plan for the drug market and NOX's impressive pipeline from 2020-02-19T13:35
Tim speaks with Noxopharm (ASX:NOX) Executive Chairman and CEO, Graham Kelly
Listen
Coronavirus, HIV and Hepatitis are in the sights of Aussie biotech Biotron from 2020-02-12T14:58
In this episode Tim chats with Dr Michelle Miller, chief executive officer and managing director of Biotron Limited (ASX:BIT).
Listen
Novel gene targeting therapies, protein disruptors and why ANP's recent trial success have investors buzzing from 2020-02-05T15:01
Tim speaks with Antisense (ASX:ANP) managing director and CEO, Mark Diamond
Listen
Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles from 2020-01-29T18:33
Tim chats with Carl Stubbings, CEO and MD of Sienna Cancer Diagnostics (ASX:SDX).
Listen
Commercialising orphan drugs, the need for better biotech regulation the ASX's lifestyle play problems from 2019-12-18T18:00
Tim chats with Race Oncology (ASX:RCE) CEO Peter Molloy and executive director and CSO Daniel Tillett.
Listen
The science behind 2019's hottest IPO and the company's next steps from 2019-12-11T14:41
Tim chats with Osteopore (ASX:OSX) executive director Geoff Pocock
Listen
Investing in repurposed drugs, combatting intracranial pressure and why Invex caught NASA's eye from 2019-12-04T16:55
Tim speaks with Invex founder and CEO Alex Sinclair, as well as the company's chairman Dr Jason Loveridge.
Listen
What's holding back better breast cancer detection? And how is Volpara's tech changing the game? from 2019-11-27T17:19
Tim chats with executive director and CEO of Volpara Health Technologies Ralph Highnam.
Listen
Developing drugs, fighting fibrosis and squeezing squishometers from 2019-11-20T16:58
Tim chats with CEO and MD Dimerix Nina Webster, and CEO of Pharmaxis Gary Phillips.
Listen
How Aussie health stocks are performing internationally and Prescient's cancer-blocking innovation from 2019-11-13T15:08
Tim chats with Steven Yatomi-Clarke, CEO and managing director of Prescient Therapeutics (ASX:PTX).
Listen
The growth of musculoskeletal disorders, new markets created by ageing populations and OCC's Avatar moment from 2019-11-06T17:10
Tim chats all things regenerative medicine with Paul Anderson, founder and CEO of Orthocell (ASX:OCC).
Listen
The future of X-ray, a new way to image the body and challenging clinical practice. from 2019-10-29T12:56
Tim chats with Michael Harsh, non-executive director at Imagion Biosystens (ASX:IBX).
Listen
The death of the doctor's clipboard, how Alcidion's infomatics saves lives and why it's best to bide time on a US entrance. from 2019-10-24T17:26
Tim chat's with Alcidion’s Group Managing Director, Kate Quirke.
Listen
Anatara Lifesciences: Standing out in the gut health market, solving scours in livestock and the future of antibiotics in the food chain. from 2019-10-16T17:36
Tim chats with Steven Lydeamore, CEO of Anatara Lifesciences (ASX:ANR).
Listen
Kazia Therapeutics: Beating glioblastoma, crossing the blood-brain barrier and the joys of receiving a gong from Jacinda Ardern. from 2019-10-09T17:07
Tim chats with Dr James Garner, CEO & Executive Director of Kazia Therapeutics (ASX:KZA).
Listen
BioScience Managers: Folding and holding in the biotech game, the perils of an early IPO and the slow burn of the Aussie health sector. from 2019-09-30T16:51
Tim chats with Matt McNamara, CIO of international healthcare investment firm BioScience Managers.
Listen
Oventus Medical: The war on snoring, spousal homicide and the mouth guard that caught Alan Moss'eye. from 2019-09-25T18:28
Tim chats with Chris Hart, founder, managing director and CEO of Oventus Medical (ASX:OVN)
Listen